ID

43211

Description

ODM derived from http://clinicaltrials.gov/show/NCT00168051

Lien

http://clinicaltrials.gov/show/NCT00168051

Mots-clés

  1. 05/12/2011 05/12/2011 -
  2. 13/04/2014 13/04/2014 - Julian Varghese
  3. 10/08/2014 10/08/2014 - Martin Dugas
  4. 20/09/2021 20/09/2021 -
Téléchargé le

20 septembre 2021

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility NCT00168051 Hemophilia A

Eligibility

  1. StudyEvent: Eligibility
    1. Eligibility
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI-1
C1512693
18 Years to 64 Years
Description

Age

Type de données

boolean

Alias
UMLS CUI-1
C0001779
Male
Description

Male gender

Type de données

boolean

Alias
UMLS CUI-1
C0086582
Severe hemophilia A
Description

Severe hemophilia A

Type de données

boolean

Alias
UMLS CUI-1
C0019069
Previously treated patients with at least 150 exposure days to any Factor VIII product
Description

Treatment with Factor VIII

Type de données

boolean

Alias
UMLS CUI-1
C0087111
UMLS CUI-2
C0015506
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI-1
C0680251
Hypersensitivity to any recombinant Factor VIII product
Description

Hypersensitivity Factor VIII

Type de données

boolean

Alias
UMLS CUI-1
C0020517
UMLS CUI-2
C0015506
History of or current Factor VIII inhibitor
Description

Factor VIII inhibitor

Type de données

boolean

Alias
UMLS CUI-1
C0368953
Bleeding episode or other reason requiring Factor VIII treatment within 3 days of study
Description

Bleeding episode

Type de données

boolean

Alias
UMLS CUI-1
C0005779

Similar models

Eligibility

  1. StudyEvent: Eligibility
    1. Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Inclusion Criteria
C1512693 (UMLS CUI-1)
Age
Item
18 Years to 64 Years
boolean
C0001779 (UMLS CUI-1)
Male
Item
Male
boolean
C0086582 (UMLS CUI-1)
Hemophilia A
Item
Severe hemophilia A
boolean
C0019069 (UMLS CUI-1)
Treatment with Factor VIII
Item
Previously treated patients with at least 150 exposure days to any Factor VIII product
boolean
C0087111 (UMLS CUI-1)
C0015506 (UMLS CUI-2)
Item Group
Exclusion Criteria
C0680251 (UMLS CUI-1)
Hypersensitivity Factor VIII
Item
Hypersensitivity to any recombinant Factor VIII product
boolean
C0020517 (UMLS CUI-1)
C0015506 (UMLS CUI-2)
Factor VIII inhibitor
Item
History of or current Factor VIII inhibitor
boolean
C0368953 (UMLS CUI-1)
Bleeding episode
Item
Bleeding episode or other reason requiring Factor VIII treatment within 3 days of study
boolean
C0005779 (UMLS CUI-1)

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial